• Explore /
  • Poster
  • / Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma.

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with ipilimumab and nivolumab, in patients with neuroendocrine carcinoma.

Abstract Poster

Authors

Patrick McGarrah

Patrick Walsh McGarrah

Mayo Clinic, Rochester, MN

Patrick Walsh McGarrah , Shruthi Naik , Thorvardur Ragnar Halfdanarson , Kah Whye Peng , Stephen J. Russell , Julian R. Molina , Alex A. Adjei

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03647163

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS602)

DOI

10.1200/JCO.2024.42.3_suppl.TPS602

Abstract #

TPS602

Poster Bd #

P18

Abstract Disclosures

Similar Posters

First Author: Patrick Walsh McGarrah

First Author: Rohit K. Jain

First Author: Lorenzo Pilla

Poster

2023 ASCO Genitourinary Cancers Symposium

A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases.

A phase II study of nivolumab with ipilimumab and cabozantinib in patients with untreated renal cell carcinoma brain metastases.

First Author: Jianbo Wang